Wells Fargo & Company Begins Coverage on Kestra Medical Technologies (NASDAQ:KMTS)

Stock analysts at Wells Fargo & Company began coverage on shares of Kestra Medical Technologies (NASDAQ:KMTS) in a research note issued on Monday, MarketBeat Ratings reports. The brokerage set an “overweight” rating and a $28.00 price target on the stock. Wells Fargo & Company‘s price objective suggests a potential upside of 16.52% from the stock’s current price.

Other analysts have also issued reports about the company. Stifel Nicolaus initiated coverage on Kestra Medical Technologies in a research note on Monday. They set a “buy” rating and a $28.00 price target on the stock. Piper Sandler assumed coverage on Kestra Medical Technologies in a research note on Monday. They issued an “overweight” rating and a $27.00 price objective for the company. Finally, The Goldman Sachs Group assumed coverage on shares of Kestra Medical Technologies in a report on Monday. They set a “neutral” rating and a $24.00 target price on the stock. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $27.67.

Kestra Medical Technologies Price Performance

NASDAQ:KMTS traded down $1.67 during mid-day trading on Monday, hitting $24.03. The company had a trading volume of 25,324 shares, compared to its average volume of 276,357. Kestra Medical Technologies has a fifty-two week low of $20.00 and a fifty-two week high of $26.06.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.